Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001949846-24-000285
Filing Date
2024-05-22
Accepted
2024-05-22 12:42:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2687
  Complete submission text file 0001949846-24-000285.txt   4031
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Subject) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-15024 | Film No.: 24972638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address GRELLINGERSTRASSE 82 BASEL V8 4052
Business Address
Gal Aharon (Reporting) CIK: 0002023443 (see all company filings)

Type: 144